2C27.1

ICD-11 MMS 2026-01

Carcinoid tumour or other neuroendocrine neoplasms of thymus

Description

Thymic neuroendocrine carcinoma is a type of thymic epithelial neoplasm displaying evidence of neuroendocrine differentiation.

Coding note from above levels

For use of this category, reference should be made to the mortality coding rules and guidelines in the Reference Guide.

Index terms

  • Carcinoid tumour or other neuroendocrine neoplasms of thymus
  • Thymic endocrine tumour
  • Thymic neuroendocrine carcinoma
Show allHide
  • Moderately-differentiated thymic neuroendocrine carcinoma
  • Poorly-differentiated thymic neuroendocrine carcinoma
  • Well-differentiated thymic neuroendocrine carcinoma
  • Large cell neuroendocrine carcinoma of thymus
  • Small cell carcinoma of thymus
  • Thymic neuroendocrine tumour

Exclusions from above levels

  • 2E0Y – Malignant neoplasm metastasis in thymus gland
  • http://id.who.int/icd/entity/1965082709 – Malignant mesenchymal neoplasms
  • 2C51.2 – Mesotheliomas of peritoneum
Show allHide
  • http://id.who.int/icd/entity/879154182 – Neoplasms of central nervous system or related structures
  • http://id.who.int/icd/entity/944754984 – Neoplasms of haematopoietic or lymphoid tissues

Sibling codes

  • 2C27.0 – Carcinoma of thymus
  • 2C27.2 – Thymoma
  • 2C27.Y – Other specified malignant neoplasms of thymus
  • 2C27.Z – Malignant neoplasms of thymus, unspecified

Foundation entity

Carcinoid tumour or other neuroendocrine neoplasms of thymus – http://id.who.int/icd/entity/381956131

Allowed postcoordination axes

Part of: 2C27: Malignant neoplasms of thymus › 02: Neoplasms